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Abstract

Liver lipid changes in male BALB-c nude mice due to subcutaneously implanted human prostate metastatic grade IV
adenocarcinoma was studied. The prostate cancer cells were cultured in F12 plus 7.5% horse serum and 25% fetal calf
serum medium. When they reached confluence, some of these cells were fixed with glutaraldehyde and thoroughly
washed with buffer then 4 x 10 7 cells were implanted into four mice. Four more mice were implanted with 4 x 106 viable,
unfixed cells. Four uninjected mice served as controls. All the mice were sacrificed 18 days later. The total liver lipids
(TLL) from each liver were extracted with chloroformrmethanol and dried in separate vials under a stream of gaseous
nitrogen. While being dried, the TLL of each liver sample were weighed intermittently until their weight remained constant. The weight of TLLin each vial was then divided by the wet weight of each corresponding extracted liver. This was
done to normalize the liver lipids in terms of one gram of liver because livers of different wet weights were extracted. The
TLL per gram of wet liver were similar in the control and livers ofmice injected with viable cancerous cells and decreased
in the livers of mice injected with glutaraldehyde-fixed cells. When the total lipids were fractionated into polar and nonpolar lipids on silicic gels, entirely different changes were seen. The TLLof the mice injected with untreated viable cancer
cells and those injected with glutaraldehyde-fixed cells were similar while the control liver lipids classes were significantly
different. There was a decrease in the percentage of neutral lipids and an increase in the polar fractions in the two groups
of mice injected with either cells. The growth of the viable injected prostate cells did not cause any unique lipidchanges
in these two lipid class profiles. However, the triglycerides and total cholesterol showed wide variations among the livers
of mice injected with viable cancer cells. The ratio of the polar/neutral lipids did not differ between the mice injected
witheither cells. Thus, the present study does not support the accepted explanation that the rapidly growing cancer cells
are mainly responsible for the lipidchanges seen in animals implanted with other types of tumor cells.

Introduction

The idea that a growing tumor may influence metabolism in tissues remote from its site is a fascinating one
since it implies the existence of a humoral agent that
could possibly be intercepted to study and control tumor
growth. Indeed, several investigators have obtained evidence that the turnover of liver lipids is profoundly
changed in animals bearing a variety of tumors (Weber
and Cantero, 1959; Stein et al., 1965; Stein et al., 1966;
Wood, 1975; Ruggieri et al., 1976; Redgrave et al., 1984).
These altered turnover rates are reflected in the composition of the liver lipids and may indeed reveal a major
source of substrate and energy for tumor growth.
Stein and his co-workers (1965, 1966) considered that
the adipose tissue may be the ultimate source of triglyceride fatty acids for this purpose, since it has been
observed in many studies that this tissue is depleted durng tumor growth (Wood et al., 1974). The consequent
changes taking place in the liver may represent an inter-

mediate transport mechanism by which the fatty acids are
efficiently furnished to the neoplastic cells. These fatty
acids could consist of the essential fatty acids necessary
for membrane formation and cell growth as well as a general mixture of the usual 16-and 18- carbon acids for energy. Since fatty acids for these purposes may be derived
from the diet, synthesized in other tissues, or released
from stored trigylcerides, it has not been easy to predict
in many cases, or to interpret the changes in the fatty
acids themselves, particularly since some of the enzymes
involved in fatty acids alteration are missing or have
escaped control in the tumor (Chiappe et al., 1974).
However, the changes in the lipids, which must be synthesized in the tissues themselves by known pathways, may
be very revealing.
Nakazawa and Mead (1976) measured the alterations
in liver lipids in female BALB-c nude mice bearing transplanted cells from a human ovarian adenocarcinoma and
reported significant changes in the phospholipidrtriglyceride (PL:TL) ratio brought about by increases in the
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>hospholipid fraction and decreases in the triglyceride
raction. This system was proposed as a model for studyng similar changes seen in the liver lipids of human
>atients (Nakazawa and Yamagata, 1971). However, in
lese earlier experiments, the degree of tumor metastatic
jrade, as well as the cell numbers implanted in the mice
were not characterized and quantified. Such lack of preise number of the implanted cells as well as varying
egree of grades of the tumor metastasis level might have
>een the cause for the disparities seen in different studies
one using freshly obtained human tissues as the source
fcells to implant into mice.
order to obviate some of the problems and gain
irther information on the mechanisms producing liver
langes, the present study was done using an established
onal cell line derived from a human metastatic prostate
•ade IVadenocarcinoma. This permitted a more quantitive injection and, in addition, treatment of some of the
:11s byglutaraldehyde.

Iln

Materials and Methods

Darmstadt). The thin layer plates were developed using a
mixture of solvents composed of ethyl ether (redistilled
and collected between 60-70 °C), petroleum ether, acetic
acid (20:80:1), or chloroform. The developed plates were
sprayed with cupric acetate-phosphoric acid reagent and
charred in an oven at 140°C (Fewster et al., 1969). The
relative proportions of the separated components were
measured using a Kontes densitometer (K-495000 connected to K-495150 integrator), and quantified using
comparison with standards spotted on the same plates.
Analysis of Component Fatty Acids. Aliquots of lipid
samples were converted into methyl esters by methanolysis, using 5% methanolic HCL. The methyl esters of the
component fatty acids were separated and quantified on a
Beckman gas chromatograph (6C-M) fitted with disc integrator and using a 6' x 3/8" column of siliac IOC. The
chromatograph was operated at 185 °C. Areas under the
peaks were read from the integrator.

—

Table 1. Distribution of lipids in livers of control and
injected mice.
Treatment ofMice

Chloroform, methanol, petroleum ether, and pentane
were reagent grade and were distilled before use. Ethyl

ther was used directly from a freshly opened can of
eagent grade ether. Other reagents were also reagent
jrade. Standards for gas-liquid chromatography were
btained from NU-Chek Prep, Elysian, Minnesota and
Applied Science Laboratory (State College, Pennsylvania).
Treatment of Animals. Male BALB-c nude mice 19
eeks old were divided into three groups and treated as
dlows. Four control mice (group 1) were not injected. In
¦oup 2 four experimental mice were injected subcutasously on the right side with 0.2 ml (4 by 106 cells) of
:11s from cell line PC 3, a human metastatic prostate
•ade IVcarcinoma, cloned and cultured inF12 plus 7.5%
Drse serum and 25% fetal calf serum. Four mice, making
oup 3, were injected with the same type of cells but
hich had been fixed for one hour with 2.5% glutaraldein 0.1 M sodium cacodylate pH 7.4 buffer and
used 20 hr. in 0.1 M sodium phosphate buffer, pH 7.4.
tie injected and the control mice were kept for 18 days
;fore sacrifice by cervical dislocation. The livers were
moved and frozen at -80°C untilextraction.
Extraction and Analysis ofLipids. Lipids were extractlfrom liver tissue with chloroform:methanol (2:1) and,
ter washing, the solvent was removed in a stream of
trogen at less than 40 °C. The total lipids in each sample
:re separated into non-polar and polar fractions by elu:>n from small silicic acid columns with chloroform and
ethanol, respectively.
Portions of neutral fractions were separated into comnents on thin-layer plates (silica gel GD. Merck,

—

II

Total Liver Lipida
Percent ofPolar

Lipids

Percent ofNeutral Lipids
Triglyceride b
Total Cholesterol
Ratio:
Polar Lipid/Neutral Lipid

Group 1
Uninjected

Viable Growing

Controls

Cells Injected

Group 3
Glutaraldehyde Fixed
Cells Injected

23.2±0.16
70 ±4.4
32 ±2.1
69 ±2.9
31 ±3.3
2.2±0.2

23.2±0.04
78 ±2.3*
21 ±2.1*
71 ±12.5
28 ±18.2
3.6±0.09*

19.7±0.05
77 ±2.5*
22 ±1
65.4±4.4
35 ±4.1
3.5±0.26'

(4) c

(4) c

(4)C

Allstatistical comparisons were done using student's test.
aValues are of mean + S.D. of mg per g wet wt of livers,

expressed as

percent

ofneutral lipids.

cNumber ofmice in each group. The liver from each mouse was separately
analyzed.
? Significantly different

from controls

—

1

Group 2

at

the 0.01 level.

Results

—

Distribution of Lipids. The state of the injected cells
did not change the total percentage of lipids profiles in
the livers of mice (Table 1). However, there was a significantly higher proportion of polar lipid and a lower proportion of neutral lipid within the TLLin the mice injected with any of the cell preparations. This is reflected in a
highly significant difference in the ratios of polar to neutral lipids between the controls and all treated groups.
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there were no significant differences in these
values among the treated groups (Table 2).
Within the neutral lipid fractions, there was considerable variation in the proportions of triglycerides and total
cholesterol as reflected in the standard deviations. This
variability was also apparent in the distribution of free
and esterified cholesterol. The meaning of these changes
is not apparent. Among the fatty acids, there were no significant differences attributed to the treatment of the
mice though the usual differences (Table 2) in neutral
and polar lipids were seen.
Moreover,

Table 2. Distribution of major fatty acids in polar and
neutral lipids of control and injected mice (mean of relative percentages + SD)
A.Polar Lipids
(4)
Group I

16:0

Uninjected Control 22.8+4.6

16:1

18:0

1.03+0.7

18.6±1

18:1

18:2

20:4

22:6

11.6±0.95 20.6±5.01 17.2+0.24 4.8±0.81

Group 2 (4)
Viable Cells

Injected

27.9+4.5

0.25±1.0 12.0±7.8 14.9+4.04

18.4±6.02 18.8±1.82 4.0±1.75

Group 3 (4)
jlutaraldehyde
Fixed Cells Injected 25.3±3.7

0.2±0.02 21.1±0.07 12.3±1.3

16.0±1.05 20.4±1.35 3.3±2.25

B.Neutral Lipids

Group 1(4)
Uninjected Control 30.9±2.88 2.03±1.25 3.08±0.43 39.4±4.57 16.88±2.13 1.2±0.78

0

Group 2 (4)
Viable Growing
Cell Injected

0

35.88±6.74 1.83±1.94 3.85±0.94 32.38±4.92 16.53±4.92 2.35±0.41

Group 3 (4)
Glutaraldehyde
Fixed Cell Injected 32.1+1.85
"he number in parentheses
was separately analyzed.

1.5+1.66 2.65+0.35 33.65+1. 35 22.65+4.65
is the number ofmice receiving each

1.5+0.5

treatment.

0
Each liver

Discussion

The results of these experiments appear to confirm
hose of Nakazawa and Mead (1976) since there is an
ncrease in the ratio of polar lipid to neutral lipid in mice
njected with the neoplastic cells. They do not however,
onfirm the very large difference between control and
xperimental values shown in the prior study.
Explanations for these differences are not difficult to sugjest. First, whole tissue from an ovarian adenocarcinoma
was injected in the earlier study, while known numbers of
ells from an established line derived from a metastatic
>rostate adenocarcinoma
were used in the present study
with male mice. Second, two months elapsed between
njection and sacrifice in the prior experiment, thus allow-

ing for considerable cell proliferation. Third, male animals were used in the present study while females were
used in the previous one. In the present study, only two
weeks elapsed between injection and sacrifice with the
hope that changes occurring before profound generalized
metabolic changes occurred could be seen. Moreover,
since numbers of cells were not known in the previous
work, an attempt was made in the present study to compensate for the proliferation of the viable injected cells by
injecting larger numbers of the non-growing cells.
Whether for this or other reasons, no significant differences in total liver lipids were seen between the livers of
mice injected with proliferating cells and uninjected controls. However, there was a significant decrease of total
liver lipids in the livers of mice injected with non-proliferating cells. But, when the total liver lipids from each
group were fractionated into polar and non-polar components and each component expressed as a percent of the
total liver lipids for each experimental group, there was
no significant difference between the percentages in the
two groups injected with cells (Table 1). The observed
changes, therefore, cannot be a result of rapid growth of
the injected neoplastic cells, but must depend on some
other unknown cause. Such a cause might be attributed
to the reactions of the injected cells with the host animal
immune response. The reaction may be to increase the
availability to the foreign cells of fatty acids needed for
growth and energy demands. In the present case however, only in one of the groups were the foreign cells able to
utilize the fatty acids. With the possible exception of 18:1
and 16:1 (Table 2) the lack of significant change in the
fatty acids of neutral and polar lipids may indicate that
there was no selective use of theses as opposed to utilization of the entire complement of the lipid involved.
Kampschmidt and Upchurch (1966) have called attention to the fact that the site of tumor transplant in an animal may lead to variation in the results obtained. We do
not know whether this is also true as far as lipids are concerned. Total cholesterol in the control mice was constant, whereas in the mice bearing cells, there were some
fluctuations as reflected in the large standard deviations
(Table 2) with most variations in the mice injected with
viable cells. Failure to find a substantial decrease of
triglycerides in the lipids of mice injected with viable cells
does not seem to support the notion frequently cited that
the decrease is due to the presence of a tumor (Stein et
al., 1965; Stein et al., 1966). These animals did not show
any gross pattern of lipid loss. It was not possible to tell
the experimental from the control mice in this respect.
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